Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins B-raf | 4 | 2022 | 154 | 1.840 |
Why?
|
| Neoplasms | 11 | 2023 | 3117 | 1.390 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2021 | 57 | 1.320 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 4 | 2021 | 7 | 1.290 |
Why?
|
| Melanoma | 3 | 2018 | 482 | 0.910 |
Why?
|
| Mutation | 6 | 2021 | 4204 | 0.900 |
Why?
|
| Phosphorylation | 10 | 2021 | 1142 | 0.890 |
Why?
|
| Tyrosine | 4 | 2014 | 133 | 0.870 |
Why?
|
| Oleic Acids | 1 | 2023 | 26 | 0.870 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2021 | 307 | 0.840 |
Why?
|
| Phosphoglycerate Mutase | 2 | 2013 | 4 | 0.820 |
Why?
|
| Glycolysis | 4 | 2014 | 184 | 0.790 |
Why?
|
| Mice, Nude | 8 | 2019 | 828 | 0.760 |
Why?
|
| Gluconates | 2 | 2019 | 13 | 0.760 |
Why?
|
| Phospholipids | 1 | 2022 | 112 | 0.750 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2019 | 68 | 0.740 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 462 | 0.710 |
Why?
|
| Mitochondria | 3 | 2016 | 599 | 0.700 |
Why?
|
| Cell Proliferation | 10 | 2019 | 1720 | 0.700 |
Why?
|
| Protein Phosphatase 2 | 1 | 2019 | 17 | 0.650 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 624 | 0.640 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2010 | 9 | 0.620 |
Why?
|
| Cell Line, Tumor | 11 | 2019 | 2669 | 0.600 |
Why?
|
| Lysine | 3 | 2021 | 181 | 0.600 |
Why?
|
| Phosphogluconate Dehydrogenase | 2 | 2015 | 3 | 0.580 |
Why?
|
| Chondroitin Sulfates | 1 | 2018 | 43 | 0.580 |
Why?
|
| Carcinogens | 1 | 2018 | 112 | 0.560 |
Why?
|
| Dietary Supplements | 1 | 2018 | 126 | 0.550 |
Why?
|
| Ketone Bodies | 1 | 2017 | 16 | 0.540 |
Why?
|
| Mice | 13 | 2023 | 12110 | 0.540 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2016 | 13 | 0.540 |
Why?
|
| Dietary Fats | 1 | 2017 | 136 | 0.510 |
Why?
|
| Protein Binding | 4 | 2021 | 1513 | 0.470 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 815 | 0.460 |
Why?
|
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2014 | 2 | 0.460 |
Why?
|
| NADP | 3 | 2021 | 49 | 0.450 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 86 | 0.430 |
Why?
|
| Phosphotyrosine | 1 | 2013 | 33 | 0.410 |
Why?
|
| Animals | 14 | 2023 | 28003 | 0.410 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 606 | 0.400 |
Why?
|
| Leukemia | 1 | 2014 | 321 | 0.390 |
Why?
|
| Pyruvate Kinase | 1 | 2009 | 14 | 0.330 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 206 | 0.320 |
Why?
|
| HT29 Cells | 2 | 2019 | 50 | 0.310 |
Why?
|
| Enzyme Activation | 3 | 2019 | 698 | 0.300 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2023 | 68 | 0.300 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2019 | 13 | 0.290 |
Why?
|
| Acetylation | 2 | 2021 | 146 | 0.290 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2007 | 22 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2018 | 502 | 0.270 |
Why?
|
| NIH 3T3 Cells | 2 | 2018 | 111 | 0.270 |
Why?
|
| Glucosephosphate Dehydrogenase | 2 | 2019 | 18 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 200 | 0.260 |
Why?
|
| HEK293 Cells | 2 | 2019 | 666 | 0.260 |
Why?
|
| K562 Cells | 2 | 2019 | 47 | 0.250 |
Why?
|
| Protein Multimerization | 2 | 2019 | 184 | 0.250 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 734 | 0.240 |
Why?
|
| Humans | 17 | 2023 | 92337 | 0.240 |
Why?
|
| Tumor Burden | 2 | 2019 | 314 | 0.220 |
Why?
|
| Dairy Products | 1 | 2023 | 11 | 0.220 |
Why?
|
| Red Meat | 1 | 2023 | 10 | 0.220 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2016 | 19 | 0.220 |
Why?
|
| Fatty Acids, Volatile | 1 | 2023 | 36 | 0.220 |
Why?
|
| Milk | 1 | 2023 | 55 | 0.210 |
Why?
|
| Sheep | 1 | 2023 | 249 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2019 | 3508 | 0.210 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2023 | 109 | 0.210 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 342 | 0.210 |
Why?
|
| Cattle | 1 | 2023 | 380 | 0.210 |
Why?
|
| Glyceric Acids | 2 | 2013 | 3 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 1091 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 1310 | 0.200 |
Why?
|
| Cyclic AMP | 1 | 2023 | 280 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 1076 | 0.200 |
Why?
|
| Ribulosephosphates | 2 | 2019 | 2 | 0.200 |
Why?
|
| Phospholipases A2 | 1 | 2022 | 44 | 0.200 |
Why?
|
| Platelet Activating Factor | 1 | 2022 | 53 | 0.190 |
Why?
|
| Ketoglutaric Acids | 1 | 2021 | 13 | 0.190 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2394 | 0.190 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 80 | 0.180 |
Why?
|
| Neoplasms, Experimental | 2 | 2014 | 270 | 0.170 |
Why?
|
| Acetoacetates | 2 | 2017 | 3 | 0.170 |
Why?
|
| A549 Cells | 1 | 2019 | 47 | 0.160 |
Why?
|
| src-Family Kinases | 1 | 2019 | 76 | 0.160 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 370 | 0.160 |
Why?
|
| MCF-7 Cells | 1 | 2019 | 117 | 0.160 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 155 | 0.150 |
Why?
|
| Janus Kinase 2 | 1 | 2019 | 59 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 403 | 0.150 |
Why?
|
| Casein Kinase II | 1 | 2018 | 11 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2013 | 1336 | 0.150 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 130 | 0.150 |
Why?
|
| Antinematodal Agents | 1 | 2018 | 9 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 221 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 76 | 0.140 |
Why?
|
| Models, Biological | 2 | 2019 | 1786 | 0.140 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2017 | 6 | 0.140 |
Why?
|
| Pyrones | 1 | 2017 | 8 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 142 | 0.140 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 101 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 505 | 0.130 |
Why?
|
| Disease Management | 1 | 2019 | 340 | 0.130 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 118 | 0.130 |
Why?
|
| Hypolipidemic Agents | 1 | 2017 | 99 | 0.130 |
Why?
|
| Metallochaperones | 1 | 2015 | 3 | 0.130 |
Why?
|
| Lipogenesis | 1 | 2015 | 25 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 250 | 0.120 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2015 | 19 | 0.120 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2015 | 7 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2016 | 190 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2015 | 39 | 0.120 |
Why?
|
| Copper | 1 | 2015 | 78 | 0.120 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 124 | 0.120 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2015 | 186 | 0.120 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 398 | 0.120 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2014 | 1 | 0.110 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2014 | 1 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 622 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1589 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 598 | 0.110 |
Why?
|
| Sirtuin 3 | 1 | 2014 | 37 | 0.110 |
Why?
|
| Female | 4 | 2021 | 47893 | 0.110 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 2013 | 4 | 0.100 |
Why?
|
| Enzyme Stability | 1 | 2013 | 41 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2447 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 2074 | 0.100 |
Why?
|
| Binding, Competitive | 1 | 2012 | 146 | 0.100 |
Why?
|
| Histidine | 1 | 2013 | 75 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 2368 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 3017 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1240 | 0.090 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 33 | 0.080 |
Why?
|
| Fructosediphosphates | 1 | 2009 | 2 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 1684 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2009 | 277 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 251 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 319 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 498 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 569 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 561 | 0.070 |
Why?
|
| Proteomics | 1 | 2009 | 246 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 122 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 98 | 0.070 |
Why?
|
| Actins | 1 | 2010 | 470 | 0.070 |
Why?
|
| Glucose | 1 | 2009 | 684 | 0.070 |
Why?
|
| RNA Interference | 1 | 2007 | 384 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1807 | 0.060 |
Why?
|
| Disease Progression | 1 | 2010 | 1503 | 0.060 |
Why?
|
| Cell Line | 1 | 2009 | 2505 | 0.060 |
Why?
|
| Male | 3 | 2021 | 43925 | 0.060 |
Why?
|
| Binding Sites | 1 | 2007 | 1130 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2015 | 466 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1743 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2015 | 358 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2015 | 110 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 731 | 0.020 |
Why?
|